Kavernöz Hemanjiom Tedavisi Sonrası Cushing Sendromu Gelişen Olguda Geçici Hipertansiyon

Yıl 2007, Cilt: 8 Sayı: 2 , 41 - 43 , 01.08.2007

Tolga Altuğ Şen Hamide Melek Reşit Köken Adnan Narci

https://izlik.org/JA77JA33HP

Öz

Anahtar Kelimeler

-

Kavernöz Hemanjiom Tedavisi Sonrası Cushing Sendromu Gelişen Olguda Geçici Hipertansiyon

https://izlik.org/JA77JA33HP

Öz

Kortikosteroidler değişik hastalıkların tedavisinde yaygın olarak kullanılmaktadır. Kullanımları sırasında bazı hastalarda geri dönüşümlü hipotalamo-pituiter-adrenal yolunun baskılanmasına neden olabilmektedirler. Sağ göz kapağının üzerindeki kavernöz hemanjiom nedeniyle iki ay boyunca farmakolojik dozda topikal kortikosteroid kullanımı sonucu Cushing sendromu gelişen 9 aylık kız hasta sunulmuştur

Anahtar Kelimeler

Cushing sendromu , oral kortikosteroid , kavernöz hemanjiom , hipertansiyon

Kaynakça

• Kandemir N. Adrenal Hastalıklar. Günöz H, Öcal G, Yordam N, Kurtoğlu S (Editörler). Pediatrik Endok- rinoloji, Pediatrik Endokrinoloji ve Oksoloji Derneği Yayınları: 1, pp: 361-414.
• Miller WL. The adrenal cortex and its disorders. In: Brook CGD, Hindmarsh PC, eds. Clinical pediatric endocrinology, 4th ed. Oxford: Blackwell Science, 2001:321–76.
• Root AW, Shulman DI. Clinical Adrenal Disorders. In: Pescovitz OH, Eugster EA, editors, Pediatric Endocrinology. Philadelphia: Lippincott Willams and Wilkins 2004. pp: 568-600.
• Abma EM, Blanken R, De Heide LJ. Cushing's syndrome caused by topical steroid therapy for psoriasis. Neth J Med. 2002; 60: 148-50.
• Halverstam CP, Vachharajani A, Mallory SB. Cushing syndrome from percutaneous absorption of 1% hydrocortisone oinment in Netherton syndrome. Pediatr Dermatol 2007; 24: 42-5.
• Sıklar Z, Bostanci I, Atlı O, Dallar Y. An infantile Cushing syndrome due to misuse of topical steroid. Pediatr Dermatol. 2004; 21: 561-3.
• Ermiş B, Ors R, Tastekin A, Ozkan B. Cushing's syndrome secondary to topical corticosteroids abuse. Clin Endocrinol. 2003; 58: 795-6.
• Allen DB. Safety of inhaled corticosteroids in children. Pediatr Pulmonol 2002; 33: 208–20.
• Perry RJ, Findlay CA, Donaldson MDC. Cushing’s syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids. Arch Dis Child. 2002; 87 :45–8.
• Ozerdem U, Levi L, Cheng L, Song MK, Scher C, Freeman WR. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Am J Ophthalmol 2000; 130: 240–1.
• Teelucksingh S, Balkaran B, Ganeshmoorthi A, Arthur P. Prolonged childhood Cushing’s syndrome secondary to intralesional triamcinolone acetonide. Ann Trop Paediatr. 2002; 22: 89–91.
• Steelman J, Kappy M. Adrenal suppression and growth retardation from ocular corticosteroids. J Pe- diatr Ophthalmol Strabismus. 2001; 38: 177–8.
• Bernstein D. Evaluation of the cardiac system. In: Nelson Textbook of Pediatrics Kleigman RM, Behrman RE (eds). 2007, pp:1861-2.
• Mafee MF, Atlas SW, Galetta SL. Eye, orbit; and visual system. In: Atlas SW, ed. Magnetic Resonance Imaging of the Brain and Spine. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2002; pp: 1480-4.
• Haik BG, Karcioğlu ZA, Gordon RA, Pechous BP. Capillary hemangioma (infantile periocular hemangioma). Surv Ophthalmology 1994; 38: 399- 426.
• Gunalp I, Gunduz K. Vascular tumors of the orbit. Doc Ophthalmol 1995; 89: 337-45.
• Wróblewska E, Toczołowski J. Treatment of eyelid hemangioma in children with intralesional steroid injection. Klin Oczna. 2001; 103: 229-31.
• Jalil S, Akhtar J, Ahmed S. Corticosteroids therapy in the management of infantile cutaneous hemangiomas. J Coll Physicians Surg Pak. 2006; 16: 662-5.
• Migeon CJ. Adrenal cortex. In: Lifshitz F (ed). Pediatric Endocrinology (3rd ed., revised and expanded). New York: Markel Dekker, Inc, 2003: 147-74.
• Hendrikse JC, Molenaar AJ. Adrenal and pituitary function during long-term topical steroid therapy. Dermatologica 1972; 144:179-180.
• Hogan DJ, Sibley JT, Lane PR. Avascular necrosis of the hips following long-term use of clobetasole propionate. J Am Acad Dermatol 1986; 14: 515-7.
• Katsushima H, Souma K, Nishio C. Glaucoma and posterior subcapsular cataract after long-term use of corticosteroid lotion in case with photodermatitis. Jpn J Clin Ophthalmol 1986; 40: 1345-9.
• Seth A, Aggarwal Anu. Monitoring adverse reactions to steroid therapy in children. Indian Pediatrics 2004; 4: 349-57.
• Cave A, Arlett P, Lee E. Inhaled and nasal corticosteroids: Factors affecting the risk of systemic adverse effects. Pharmacol Therapy. 1999; 83: 153- 79.
• Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr, et al. Cushing’s syndrome in children and adolescents. Presentation, diagnosis and therapy. New Eng J Med 1994; 331: 629-39.
• Chamberlin P, Meyer WJ. Management of pituiary- adrenal suppression secondary to corticosteroid therapy. Pediatrics 1981; 67: 245-51.
• Byyney RL. Withdrawal from glucocorticoid therapy. N Engl J Med 1976; 295: 30-2.